Concepedia

Tomoko Saito

TS

Statistics

Publications

6

Citations

207

H-Index

6

Active since

2001

Affiliations

Chiba University(Current)

Tomoko Saito is an author at Chiba University specializing in oncology, hepatocellular carcinoma, and pharmacotherapy.

Publications per year

2001–2022

6

Publications

6

Liver function assessment according to the Albumin–Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinoma

Sadahisa Ogasawara, Tetsuhiro Chiba, Yoshihiko Ooka et al. · Investigational New Drugs · 2015 · 84 citations

Medicine, Oncology, Pharmacotherapy +15

Sustained virologic response achieved after curative treatment of hepatitis <scp>C</scp> virus‐related hepatocellular carcinoma as an independent prognostic factor

Naoya Kanogawa, Sadahisa Ogasawara, Tetsuhiro Chiba et al. · Journal of Gastroenterology and Hepatology · 2015 · 36 citations

Pharmacy, Oncology, Hepatitis Pharmacotherapy +15

Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors

Shin Yasui, Masato Nakamura, Eiichiro Suzuki et al. · International Journal of Molecular Sciences · 2017 · 31 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy of transarterial chemoembolization targeting portal vein tumor thrombus in patients with hepatocellular carcinoma.

Akinobu Tawada, Tetsuhiro Chiba, Yoshihiko Ooka et al. · PubMed · 2014 · 27 citations

Medicine, Oncology, Pharmacology +17

Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring <i>CTNNB1</i> Mutation in Early Clinical Experience

Keita Ogawa, Hiroaki Kanzaki, Tetsuhiro Chiba et al. · Journal of Cancer · 2022 · 19 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

1–5 of 6